ATE284697T1 - Pharmazeutische zubereitung auf der basis von rhamnolipid gegen dermatologische erkrankungen - Google Patents

Pharmazeutische zubereitung auf der basis von rhamnolipid gegen dermatologische erkrankungen

Info

Publication number
ATE284697T1
ATE284697T1 AT93914523T AT93914523T ATE284697T1 AT E284697 T1 ATE284697 T1 AT E284697T1 AT 93914523 T AT93914523 T AT 93914523T AT 93914523 T AT93914523 T AT 93914523T AT E284697 T1 ATE284697 T1 AT E284697T1
Authority
AT
Austria
Prior art keywords
rhamnolipid
pharmaceutical preparation
dermatological diseases
preparation based
mono
Prior art date
Application number
AT93914523T
Other languages
English (en)
Inventor
Goran Piljac
Visnja Piljac
Original Assignee
Paradigm Biomedical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Paradigm Biomedical Inc filed Critical Paradigm Biomedical Inc
Application granted granted Critical
Publication of ATE284697T1 publication Critical patent/ATE284697T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Birds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Cosmetics (AREA)
AT93914523T 1992-02-04 1993-02-04 Pharmazeutische zubereitung auf der basis von rhamnolipid gegen dermatologische erkrankungen ATE284697T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
BE9200115A BE1005704A4 (nl) 1992-02-04 1992-02-04 Farmaceutisch preparaat op basis van rhamnolipide.
US86669192A 1992-04-10 1992-04-10
PCT/EP1993/000270 WO1993014767A2 (en) 1992-02-04 1993-02-04 Pharmaceutical preparation based on rhamnolipid against dermatological diseases, e.g. papilloma virus infections

Publications (1)

Publication Number Publication Date
ATE284697T1 true ATE284697T1 (de) 2005-01-15

Family

ID=25662615

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93914523T ATE284697T1 (de) 1992-02-04 1993-02-04 Pharmazeutische zubereitung auf der basis von rhamnolipid gegen dermatologische erkrankungen

Country Status (11)

Country Link
EP (1) EP0630252B1 (de)
JP (2) JP3860206B2 (de)
AT (1) ATE284697T1 (de)
AU (1) AU3453493A (de)
BE (1) BE1005704A4 (de)
CA (1) CA2129542C (de)
DE (1) DE69333723T2 (de)
DK (1) DK0630252T3 (de)
ES (1) ES2235155T3 (de)
PT (1) PT630252E (de)
WO (1) WO1993014767A2 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5466675A (en) * 1992-02-04 1995-11-14 Piljac; Goran Immunological activity of rhamnolipids
EP1056462B1 (de) * 1998-02-24 2007-07-25 Paradigm Biomedical Inc. Verwendundung von Rhamnolipiden als Kosmetika
EP1889623A3 (de) * 1998-02-24 2009-04-08 Paradigm Biomedical Inc. Verwendung von Rhamnolipiden für die Wundheilung, für die Behandlung von Verbrennungen, Arteriosklerose, Organtransplantationen, Depressionen und Schizophrenie sowie für Kosmetikartikel
US7129218B2 (en) * 1999-08-05 2006-10-31 Paradigm Biomedical, Inc. Use of rhamnolipids in wound healing, treatment and prevention of gum disease and periodontal regeneration
US20040242501A1 (en) * 2003-03-20 2004-12-02 Gross Richard A. Spermicidal and virucidal properties of various forms of sophorolipids
DE102005052210A1 (de) * 2005-10-26 2007-05-03 Südzucker Aktiengesellschaft Mannheim/Ochsenfurt Mikrobiologisch stabilisiertes Bier
WO2008013899A2 (en) * 2006-07-27 2008-01-31 Aurora Advance Beauty Labs Rhamnolipid-based formulations
CN103347529B (zh) 2010-12-09 2016-10-26 Y&B妈妈之选有限公司 包含皂苷的制剂及其用途
US10434058B2 (en) 2010-12-09 2019-10-08 Y&B Mother's Choice Ltd. Natural formulations
WO2012077120A2 (en) 2010-12-09 2012-06-14 Y&B Mother's Choice Ltd. Natural formulations
DE102012221519A1 (de) * 2012-11-26 2014-05-28 Evonik Industries Ag Verfahren zur Isolierung von Rhamnolipiden
DE102013205756A1 (de) * 2013-04-02 2014-10-02 Evonik Industries Ag Mischungszusammensetzung enthaltend Rhamnolipide
EP2786742A1 (de) * 2013-04-02 2014-10-08 Evonik Industries AG Kosmetika enthaltend Rhamnolipide
WO2015194772A2 (ko) * 2014-06-20 2015-12-23 재단법인 제이씨비 공동생물과학연구소 항균 및 방부 활성을 갖는 녹농균 배양액 추출물을 포함하는 조성물 및 이의 용도
IL229836A0 (en) 2013-12-08 2014-03-31 Y & B Mother S Choice Ltd Formulations to reduce or suppress irritation to eye tissue
EP3338762A1 (de) * 2016-12-22 2018-06-27 L'oreal Verwendung von rhamnolipid zur behandlung von hautrötung
CN115884755A (zh) * 2020-08-28 2023-03-31 莱雅公司 包含糖脂和水杨酸衍生物的组合物
EP4015588A1 (de) * 2020-12-15 2022-06-22 Evonik Operations GmbH Verwendung von rhamnolipiden und/oder sophorolipiden in beschichtungszusammensetzungen zur erhaltung eines homogenen farbbildes des trockenen beschichtungsfilms und/oder zur erhöhung der arbeitssicherheit bei der herstellung von beschichtungszusammensetzungen

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4814953B1 (de) * 1970-10-14 1973-05-11
JPS60183032A (ja) * 1984-03-02 1985-09-18 Shiseido Co Ltd 乳化組成物
DD248279A1 (de) * 1984-09-07 1987-08-05 Univ Leipzig Antiphytovirale therapie mit biogenen mitteln
JPS6377533A (ja) * 1986-09-18 1988-04-07 Fujitsu Ltd 減圧処理装置の圧力切り替え方法
JPS63253025A (ja) * 1987-04-09 1988-10-20 Yamanouchi Pharmaceut Co Ltd ホスホリパ−ゼａ↓２阻害剤
FR2645741B1 (fr) * 1989-03-20 1995-06-23 Dior Christian Parfums Procede pour fixer un produit sur la membrane d'un keratinocyte au moyen d'une liaison ligand-recepteur, procede de preparation d'un tel produit, produit obtenu, composition cosmetique ou pharmaceutique le contenant et son procede de preparation

Also Published As

Publication number Publication date
ES2235155T3 (es) 2005-07-01
AU3453493A (en) 1993-09-01
JP3860206B2 (ja) 2006-12-20
PT630252E (pt) 2005-04-29
JPH09503196A (ja) 1997-03-31
DE69333723D1 (de) 2005-01-20
CA2129542A1 (en) 1993-08-05
JP2004149547A (ja) 2004-05-27
DE69333723T2 (de) 2005-12-08
EP0630252A1 (de) 1994-12-28
BE1005704A4 (nl) 1993-12-21
EP0630252B1 (de) 2004-12-15
DK0630252T3 (da) 2005-04-04
WO1993014767A2 (en) 1993-08-05
WO1993014767A3 (en) 1993-09-02
CA2129542C (en) 2008-04-22

Similar Documents

Publication Publication Date Title
ATE284697T1 (de) Pharmazeutische zubereitung auf der basis von rhamnolipid gegen dermatologische erkrankungen
NO950297D0 (no) Prolinamidderivater
DK0490667T3 (da) HIV-proteaseinhibitorer
HUP0101999A2 (hu) 4-Hidroxi-kinolin-3-karboxamid- és -hidrazid-származékok, ezeket tartalmazó gyógyászati készítmények, valamint e vegyületek alkalmazása
RU94041223A (ru) Средство для лечения мотонейроновых заболеваний
NO963053D0 (no) Kosmetiske eller farmasöytiske preparater inneholdende mangiferin eller derivater derav
DE19875016I2 (de) Nukleosidanalogen enthaltende Antiviren-Zubereitungen.
ES2148254T3 (es) Peptidos antimicrobianos ciclicos y preparacion de los mismos.
KR950031060A (ko) 골다공증 치료용 약제학적 조성물
KR890003382A (ko) 항 비루스성 화합물
FI922044A0 (fi) Ny polypeptid och daerav framstaelld hiv-medicin.
ES2051834T3 (es) El uso de tetrahidrobenzeno(c,d)indol-6 carboxamidas para la preparacion de un medicamento para el tratamiento de la ansiedad.
MD1560F2 (en) Cyclic compounds, pharmaceutical compositions on base thereof and methods of treatment of infections or diseases provoked by retroviruses.
KR970705563A (ko) 항바이러스제로서의 4-(2-아미노-6-(시클로프로필아미노)-9H-푸린-9-일)-2-시클로펜텐-1-메탄올 숙시네이트(4-(2-Amino-6-(Cyclopropylamino)-9H-Purin-9-yl)-2-Cyclopentene-1-Methanol Succinate as Antiviral Agent)
KR890005088A (ko) 4- 아미노피리딘 유도체 및 그의 산 부가염
DE68923169D1 (de) Verwendung von fluor enthaltenden Pyridoncarbonsäure-Derivaten zur Herstellung eines Arzneimittels zur Behandlung von HIV infektionen.
KR910004191A (ko) 신질환치료제
FI911875A0 (fi) Kirala 2-(fosfonometoxi) propylguaniner som antivirala aemnen.
MX9206930A (es) Nuevos compuestos
NO950177L (no) Farmakologisk aktive erivater
ATE86117T1 (de) Zusammensetzung gegen leberkrankheiten.
KR930016417A (ko) 피롤릴벤조디아제핀온
ES2169117T3 (es) Uso de derivados de 2-aminopurina en el tratamiento y profilaxis de la infeccion por el virus 7 del herpes humano.
DK165967C (da) Anvendelse af en 2-oxo-imidazolidinforbindelse til fremstilling af et farmaceutisk praeparat
NO903585L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,3-oksaziner.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0630252

Country of ref document: EP

REN Ceased due to non-payment of the annual fee